<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-943MCNY5</identifier><date>2004</date><creator>Glumac, Nebojša</creator><creator>Hočevar, Marko</creator><creator>Novaković, Srdjan</creator><creator>Snoj, Marko</creator><relation>documents/doc/9/URN_NBN_SI_doc-943MCNY5_001.pdf</relation><relation>documents/doc/9/URN_NBN_SI_doc-943MCNY5_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 150</format><identifier identifier_type="COBISSID_HOST">18875353</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-943MCNY5</identifier><language>slv</language><publisher>Kancerološko združenje Slovenskega zdravniškega društva</publisher><publisher>Onkološki inštitut</publisher><publisher>Zveza slovenskih društev za boj proti raku</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="slv">Beljakovina-tirozinska kinaza</subject><subject language_type_id="slv">Kožne novotvorbe</subject><subject language_type_id="eng">Melanom</subject><subject language_type_id="eng">Melanoma</subject><subject language_type_id="eng">Prognosis</subject><subject language_type_id="slv">Prognoza</subject><subject language_type_id="eng">Protein-Tyrosine Kinase</subject><subject language_type_id="eng">Skin Neoplasms</subject><title>Prognostična vloga tirozinazne mRNK v krvi bolnikov z malignim melanomom</title></Record>